X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-23 | NPCE | Kck Ltd. | 10% | S - Sale | $5.45 | -224,138 | 5,270,845 | -4% | -$1,221,927 | |||||
2024-10-22 | NPCE | Kck Ltd. | 10% | S - Sale | $6.09 | -4,082 | 5,494,983 | 0% | -$24,853 | ||||||
| M | 2024-10-18 | NPCE | Kck Ltd. | 10% | S - Sale | $6.21 | -8,598 | 5,499,065 | 0% | -$53,370 | |||||
| M | 2024-10-03 | NPCE | Kck Ltd. | 10% | S - Sale | $6.53 | -46,426 | 5,507,663 | -1% | -$303,367 | |||||
| M | 2024-08-30 | NPCE | Kck Ltd. | 10% | S - Sale | $6.92 | -39,684 | 5,554,089 | -1% | -$274,714 | |||||
| M | 2024-05-01 | NPCE | Orbimed Advisors LLC | 10% | S - Sale | $14.02 | -29,206 | 3,406,335 | -1% | -$409,426 | |||||
2024-04-24 | NPCE | Orbimed Advisors LLC | 10% | S - Sale | $14.06 | -1,781 | 3,435,541 | 0% | -$25,041 | ||||||
| M | 2024-04-19 | NPCE | Orbimed Advisors LLC | 10% | S - Sale | $14.12 | -64,653 | 3,437,322 | -2% | -$913,057 | |||||
| M | 2024-04-16 | NPCE | Orbimed Advisors LLC | 10% | S - Sale | $14.02 | -16,992 | 3,501,975 | 0% | -$238,231 | |||||
| M | 2024-04-11 | NPCE | Orbimed Advisors LLC | 10% | S - Sale | $14.49 | -485,000 | 3,518,967 | -12% | -$7,026,033 | |||||
| M | 2024-02-02 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $15.09 | -17,589 | 77,762 | -18% | -$265,401 | |||||
| M | 2024-01-30 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $15.09 | -13,848 | 95,351 | -13% | -$208,965 | |||||
| M | 2024-01-24 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $15.03 | -828 | 109,199 | -1% | -$12,441 | |||||
| M | 2023-12-26 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $10.12 | -13,402 | 110,027 | -11% | -$135,668 | |||||
2023-12-20 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $10.14 | -2,730 | 123,429 | -2% | -$27,695 | ||||||
2023-12-06 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $8.16 | -11,005 | 126,159 | -8% | -$89,773 | ||||||
| M | 2023-11-29 | NPCE | Kck Ltd. | 10% | S - Sale | $8.78 | -16,167 | 5,593,773 | 0% | -$141,882 | |||||
| M | 2023-11-27 | NPCE | Kck Ltd. | 10% | S - Sale | $8.87 | -11,171 | 5,609,940 | 0% | -$99,109 | |||||
| M | 2023-10-02 | NPCE | Orbimed Advisors LLC | 10% | S - Sale | $9.07 | -8,314 | 4,003,967 | 0% | -$75,449 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |